News

Healio11m
FDA clears phase 2 trial of immunoglobulin eye drops in dry eye disease
The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...
PharmExec36m
FDA Clears Investigational New Drug Application for Ascletis’ Oral IL-17 Inhibitor in Mild-to-Moderate Plaque Psoriasis
Clearance of ASC50 paves the way for a Phase I trial in patients with mild-to-moderate plaque psoriasis.
PharmTech41m
FDA Refines Regulatory Pathway for Canadian Drug Importation
Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...